Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Gook Shin

Showing results (201-210 of 256) with videos related to

Pageof 26
Sort By:
Rapid Communications in Mass Spectrometry : RCM|February 14, 2006
In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomesHyojin Kim, Suil Kang, Hyunmi Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2013
Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphismJi-Hong Shon, Young-Ran Yoon, Min-Jung Kim, et al.
Molecular Neurobiology|October 11, 2015
Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta-analysisBatoul Sadat Haerian, Larry Baum, Patrick Kwan, et al.
Scientific Reports|August 4, 2022
Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosisNguyen Phuoc Long, Nguyen Ky Anh, Nguyen Thi Hai Yen, et al.
Journal of Clinical Pharmacology|May 20, 2011
Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazoleHoon Cho, Min-Koo Choi, Doo-Yeon Cho, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 6, 2013
Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patientsKye-Min Kim, Ho-Sook Kim, Se Hun Lim, et al.
Clinical and Experimental Pharmacology & Physiology|March 25, 2015
Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi populationMuhammad Shahdaat Bin Sayeed, Mohd Nazmul Hasan Apu, Maliha Tabassum Munir, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.
Toxicology and Applied Pharmacology|July 30, 2015
Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysisEun Sook Jeong, Gabin Kim, Ho Jung Shin, et al.
Pageof 26

Showing results (201-210 of 256) with videos related to

Sort By:
Pageof 26
Rapid Communications in Mass Spectrometry : RCM|February 14, 2006
In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomesHyojin Kim, Suil Kang, Hyunmi Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2013
Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphismJi-Hong Shon, Young-Ran Yoon, Min-Jung Kim, et al.
Molecular Neurobiology|October 11, 2015
Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta-analysisBatoul Sadat Haerian, Larry Baum, Patrick Kwan, et al.
Scientific Reports|August 4, 2022
Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosisNguyen Phuoc Long, Nguyen Ky Anh, Nguyen Thi Hai Yen, et al.
Journal of Clinical Pharmacology|May 20, 2011
Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazoleHoon Cho, Min-Koo Choi, Doo-Yeon Cho, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 6, 2013
Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patientsKye-Min Kim, Ho-Sook Kim, Se Hun Lim, et al.
Clinical and Experimental Pharmacology & Physiology|March 25, 2015
Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi populationMuhammad Shahdaat Bin Sayeed, Mohd Nazmul Hasan Apu, Maliha Tabassum Munir, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.
Toxicology and Applied Pharmacology|July 30, 2015
Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysisEun Sook Jeong, Gabin Kim, Ho Jung Shin, et al.
Pageof 26